IRWD · Ironwood Pharmaceuticals Inc · Share Buybacks
$3.56
-0.20 (-5.32%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$682.44M
Shares
165.24M
Volume · Oct 2
2.69M
Avg daily vol (3M)
2.11M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$150,000,000
as of 2021-05-31
· not restated in filings since 2025-03-31
Remaining Authorization
$32,400,000
as of 2022-03-31
· not restated in filings since 2022-05-05
Program Utilization
78.4%
$117,600,000 used of $150,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $126,394,000 | 10-K, filed 2025-03-31 |
| 2021-12-31 | $24,131,000 | 10-K, filed 2024-02-16 |